Sertralinum

Readily available Recent EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 100 mg Tablets

Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Central nervous system
- Mental Health

Action: Antidepressants (CNS)

Full Description:
Sertralinum dossier 100 mg is a dossier in development. Note that the 50 mg dossier is under registration in The Netherlands

Availability and Market information:

Status: Development

Market information

Other Market Info:

Patent Information:
Name: Serlain = Lustral = Zoloft
Patent expiration date: 2005
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.